Replay available

Zai Lab Limited (ZLAB) Q1 2025 Earnings Call

Zai Lab Limited (NASDAQ: ZLAB) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Thu, May 8, 2025 at 8:00 AMendedReplay
Zai Lab Limited (ZLAB) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Christine Cho

Senior Vice President of Investor Relations

Dr. Samantha Du

Founder, CEO, and Chairperson

Josh Smiley

President and Chief Operating Officer

Dr. Rafael Amado

President and Head of Global Research and Development

Dr. Yaojin Chen

Chief Financial Officer

Michael Yee

Analyst, Jefferies

Louis Chen

Analyst, Scotiabank

Lee Watsick

Analyst, Kantor

Jonathan Wang

Chief Business Officer

Anupam Ram

Analyst, JP Morgan

Ling Haichao

Analyst, Goldman Sachs

Paul Anderson

Analyst

Linhai Zhao

Analyst, Goldman Sachs

Replay transcript excerpt

Hello, ladies and gentlemen. Thank you for standing by and welcome to Xilep's first quarter 2025 Financial Results Conference call. At this time, all participants are in listen-only mode. Later, we will conduct a question and answer session and instructions will follow at that time. As a reminder, today's call is being recorded. It is now my pleasure to turn the floor over to Christine Cho, Senior Vice President of Investor Relations. Please go ahead. Thank you, operator. Hello and welcome everyone. Today's earnings call will be led by Dr. Samantha Du, Scilab's founder, CEO, and chairperson. She will be joined by Josh Smiley, President and Chief Operating Officer, Dr. Rafael Amado, President and Head of Global Research and Development, and Dr. Yaojin Chen, Chief Financial Officer. Jonathan Wang, our Chief Business Officer, will also be available to answer questions during the Q&A portion of the call. As a reminder, during today's call, we will be making certain forward-looking statements based on our current expectations. These statements are subject to numerous risks and uncertainties that may cause actual results to differ materially from what we expect due to a variety of factors, including those discussed in our SEC filings. We will also refer to adjusted loss from operations, which is a non-GAAP financial measure. Please refer to our earnings release furnished with the SEC on May 8th, 2025 for additional information on this non-GAAP financial measure. At this time, it is my pleasure to turn the call over to Dr. Samantha Du. Thank you, Christine. Good morning and good evening, everyone. Thank you for joining us today. We entered 2025 with a conviction that this would be a pivotal year for Zalai, a year where strong execution disciplined growth, and scientific inn...

More from Zai Lab Ltd.